4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-025191
EVP, CFO & Treasurer sold 33,849 shares at an average $1.18 ($39,788)
From the SEC's structured data for this filing
Trades in this filing
Mason Michael · EVP, CFO & Treasurer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-29 | Sale : show line 1 in the form | −27,687 | $1.17 | $32,394 | 404,918 | D |
| 2024-03-01 | Sale : show line 2 in the form | −6,162 | $1.20 | $7,394 | 398,756 | D |
| Open-market sales · 33,849 sh · avg $1.18 · $39,788 | ||||||
Loading xslF345X05/ownership.xml…